NYT vs TIGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The New York Times Company exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally low Debt/Equity ratio of 0.02. However, the stock is severely overvalued, trading at $79.03 despite a Graham Number of $24.36 and an Intrinsic Value of $32.50. This valuation gap is exacerbated by a high PEG ratio of 3.79 and a bearish technical trend (10/100). While earnings beats are consistent, the combination of insider selling by the CEO and CFO and a current price exceeding the analyst target price ($74.11) suggests a significant downside risk.
TIGO exhibits a dichotomy between explosive growth and fragile financial health, evidenced by a stable but mediocre Piotroski F-Score of 4/9. While the stock trades significantly above its defensive Graham Number ($62.74), it remains well below its growth-based intrinsic value ($236.88), suggesting long-term upside if leverage is managed. However, a critical technical trend score of 10/100 and a current price ($83.43) exceeding the analyst target ($75.84) indicate a high probability of a short-term correction. The company's exceptional ROE (37.87%) is offset by a concerning Debt/Equity ratio of 2.62 and a liquidity crunch (Current Ratio 0.88).
Compare Another Pair
Related Comparisons
NYT vs TIGO: Head-to-Head Comparison
This page compares The New York Times Company (NYT) and Millicom International Cellular S.A. (TIGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.